Anna Berkenblit is VP at ImmunoGen, Inc. (IMGN). They have made 5 open-market trades across 1 company since 2017, most recently 2023-06-30.
CIK 0001691868
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMGN | 113,935 | $3.6M |
Shares reported on the most recent Form 4, priced at the 2023-07-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGN | SELL | 2020-02-24 | 2020-02-25 | $4.99 | $258K | -12.9% | -26.4% | +1.4% |
| IMGN | SELL · 10b5-1 | 2018-10-16 | 2018-10-17 | $8.00 | $47K | -29.3% | -24.7% | -33.6% |
| IMGN | SELL | 2018-09-10 | 2018-09-11 | $9.46 | $111K | -3.4% | -18.1% | -42.6% |
| IMGN | SELL | 2018-02-22 | 2019-02-25 | $5.60 | $185K | -55.8% | -57.1% | -67.1% |
| IMGN | SELL | 2018-02-21 | 2018-02-23 | $10.88 | $377K | +3.9% | +15.5% | -5.6% |
| IMGN | SELL | 2017-09-13 | 2017-09-18 | $7.00 | $11K | +10.9% | -5.0% | -6.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.